Insider Transactions Reported by 14 Insiders of Hepion Pharmaceuticals, Inc.

Symbol
HEPA, CTRVP on OTC
Location
Edison, NJ

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

Hepion Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Dr. Robert T. Foster CEO and Director, Director $153,934 18 Sep 2023
Peter Wijngaard Director $28,978 24 Nov 2023
Michael J. Purcell Director 06 Mar 2024
Cavan John T. Chief Financial Officer 18 May 2021
Timothy M. Block Director 19 Feb 2024
Thomas Adams PhD Director 18 May 2021
Arnold Lippa Director 18 May 2021
John P. Brancaccio Chairman, Director 19 Feb 2024
Anand Reddi Director 27 Jun 2022
Vincent S. LoPriore Executive Chairman, Director 16 Mar 2026
Gary S. Stetz Chief Executive Officer, Director 16 Mar 2026
Kaouthar Lbiati Director 19 Feb 2024
Sireesh Appajosyula Director 16 Mar 2026
Gary S. Jacob Director 19 Feb 2024

Recent Insider Transactions by Companies or Individuals for Hepion Pharmaceuticals, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.